Drug Discovery

Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

What role must pharma play to help improve outcomes for women?

Based in Barcelona and Belgium, this startup company is bringing small molecules to the fight against X-linked leukodystrophy

How the Emulate Colon Intestine-Chip could help researchers develop breakthrough treatments for IBD.

We spoke to the CEO who’s taking ancient Indian cannabis medicines through modern clinical trials.

We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.

Tom Mander, Chief Executive Officer of Domainex looks back on his career in small molecules and shares his hopes for the future.

A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device